超高b值DWI准确识别成人型弥漫性胶质瘤的异柠檬酸脱氢酶基因型与肿瘤亚型
这项前瞻性研究纳入70例成人型弥漫性胶质瘤患者,行多b值DWI并计算肿瘤实质与对侧正常白质的ADC比值,评估其与IDH基因型、肿瘤亚型及Ki-67状态的相关性;结果显示超高b值DWI可可靠区分IDH基因型与肿瘤亚型,且高及超高b值DWI诊断性能优于标准b值DWI。
要点
- IDH突变型胶质瘤各ADC值均显著高于IDH野生型(p<0.01),ADCb500/b8000的AUC最高为0.866。
- 胶质母细胞瘤各ADC值均显著低于星形细胞瘤(p<0.01);除ADCb500/b1000外,胶质母细胞瘤各ADC值亦显著低于少突胶质细胞瘤(p<0.05)。
- ADCb500/b8000与ADCb500/b10000在少突胶质细胞瘤中显著高于星形细胞瘤(p=0.034与0.023)。
核心结论
- 超高b值DWI可依据WHO CNS5标准可靠区分成人型弥漫性胶质瘤的IDH基因型与肿瘤亚型,并可能有助于个体化治疗与预后评估。
研究设计与样本
- 前瞻性研究纳入70例成人型弥漫性胶质瘤患者,行多b值DWI并计算肿瘤实质与对侧正常表现白质的ADC值及ADC比值,比较各b值组合的诊断性能。
关键影像表现/征象
- IDH突变型胶质瘤所有ADC值均显著高于IDH野生型(p<0.01)。
- 胶质母细胞瘤所有ADC值均显著低于星形细胞瘤(p<0.01)。
- 除ADCb500/b1000外,胶质母细胞瘤其余ADC值均显著低于少突胶质细胞瘤(p<0.05)。
- 少突胶质细胞瘤的ADCb500/b8000与ADCb500/b10000均显著高于星形细胞瘤(p=0.034与0.023)。
- 所有ADC值均与Ki-67状态呈负相关(p<0.05)。
诊断标准与关键数值
- 区分IDH基因型:ADCb500/b8000的AUC最高为0.866。
- 区分胶质母细胞瘤与星形细胞瘤:ADCb500/b6000的AUC最高为0.818。
- 区分胶质母细胞瘤与少突胶质细胞瘤:ADCb500/b8000与ADCb500/b10000的AUC最高均为0.979。
- 区分星形细胞瘤与少突胶质细胞瘤:ADCb500/b10000的AUC最高为0.773。
临床应用与阅片要点
- 高及超高b值DWI较标准b值DWI表现出更好的诊断性能,可用于辅助区分IDH基因型与肿瘤亚型。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: To distinguish isocitrate dehydrogenase (IDH) genotypes and tumor subtypes of adult-type diffuse gliomas based on the fifth edition of the World Health Organization classification of central nervous system tumors (WHO CNS5) in 2021 using standard, high, and ultra-high b-value diffusion-weighted imaging (DWI).
MATERIALS AND METHODS: This prospective study enrolled 70 patients with adult-type diffuse gliomas who underwent multiple b-value DWI. Apparent diffusion coefficient (ADC) values including ADCb500/b1000, ADCb500/b2000, ADCb500/b3000, ADCb500/b4000, ADCb500/b6000, ADCb500/b8000, and ADCb500/b10000 in tumor parenchyma (TP) and contralateral normal-appearing white matter (NAWM) were calculated. The ADC ratios of TP/NAWM were assessed for correlations with IDH genotypes, tumor subtypes, and Ki-67 status; diagnostic performances were compared.
RESULTS: All ADCs were significantly higher in IDH mutant gliomas than in IDH wild-type gliomas (p < 0.01 for all); ADCb500/b8000 had the highest area under the curve (AUC) of 0.866. All ADCs were significantly lower in glioblastoma than in astrocytoma (p < 0.01 for all). ADCs other than ADCb500/b1000 were significantly lower in glioblastoma than in oligodendroglioma (p < 0.05 for all). ADCb500/b8000 and ADCb500/b10000 were significantly higher in oligodendroglioma than in astrocytoma (p = 0.034 and 0.023). The highest AUCs were 0.818 for ADCb500/b6000 when distinguishing glioblastoma from astrocytoma, 0.979 for ADCb500/b8000 and ADCb500/b10000 when distinguishing glioblastoma from oligodendroglioma, and 0.773 for ADCb500/b10000 when distinguishing astrocytoma from oligodendroglioma. Additionally, all ADCs were negatively correlated with Ki-67 status (p < 0.05 for all).
CONCLUSION: Ultra-high b-value DWI can reliably separate IDH genotypes and tumor subtypes of adult-type diffuse gliomas using WHO CNS5 criteria.
CLINICAL RELEVANCE STATEMENT: Ultra-high b-value diffusion-weighted imaging can accurately distinguish isocitrate dehydrogenase genotypes and tumor subtypes of adult-type diffuse gliomas, which may facilitate personalized treatment and prognostic assessment for patients with glioma.
KEY POINTS: • Ultra-high b-value diffusion-weighted imaging can accurately distinguish subtle differences in water diffusion among biological tissues. • Ultra-high b-value diffusion-weighted imaging can reliably separate isocitrate dehydrogenase genotypes and tumor subtypes of adult-type diffuse gliomas. • Compared with standard b-value diffusion-weighted imaging, high and ultra-high b-value diffusion-weighted imaging demonstrate better diagnostic performances.
引用
- Wang X, Shu X, He P, et al. Ultra-high b-value DWI accurately identifies isocitrate dehydrogenase genotypes and tumor subtypes of adult-type diffuse gliomas. Eur Radiol. 2024. PMID: 38528135. doi:10.1007/s00330-024-10708-5
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。